Organogenesis Holdings ORGO
NASDAQ ORGO
$0.94 +0.03 (+3.10%)
At close: Nov 10, 2026 · 4:00 PM EST

Organogenesis Holdings (ORGO) Current Deferred Revenue (2025)

Updated

Organogenesis Holdings (ORGO) posted Current Deferred Revenue of $3.86 million for Q4 2025, down 12.2% from the prior quarter.

Analysis

Organogenesis Holdings (ORGO) Current Deferred Revenue (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 265.71 Bn 242.23 Bn 5.13 Bn
2 Abbott Laboratories 189.37 Bn 163.23 Bn 7.39 Bn
3 Danaher 164.78 Bn 144.43 Bn 3.84 Bn
4 Intuitive Surgical 157.85 Bn 138.13 Bn 2.08 Bn
5 Medtronic 129.66 Bn 94.91 Bn 6.34 Bn
6 Stryker 121.82 Bn 108.01 Bn 4.25 Bn
7 Boston Scientific 63.42 Bn 58.86 Bn 3.43 Bn
8 Edwards Lifesciences 59.49 Bn 42.69 Bn 1.35 Bn
9 Becton Dickinson 58.38 Bn 55.53 Bn 2.32 Bn
10 Organogenesis Holdings 123.06 Mn -129.42 Mn 23.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.86 Mn
Sep 30, 2025 4.40 Mn
Jun 30, 2025 4.77 Mn
API Access

Organogenesis Holdings Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ORGO&period=max&api_key=YOUR_API_KEY